Requena-Méndez, Ana <br/><br/>
Reply to "adequate design of pharmacokinetic-pharmacodynamic studies will help optimize tuberculosis treatment for the future".  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Apr 2015 
 - 2475 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.05182-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antitubercular Agents--pharmacokinetics<br/>Dietary Fats--pharmacokinetics<br/>Female<br/>Food-Drug Interactions<br/>Humans<br/>Isoniazid--pharmacokinetics<br/>Male<br/>Rifampin--pharmacokinetics<br/>Tuberculosis, Pulmonary--drug therapy